DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo.
about
Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound HealingThe clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic reviewEmerging therapeutic biomarkers in endometrial cancerEffect of Bisphenol A on invasion ability of human trophoblastic cell line BeWoDecitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts.HDAC inhibitors in experimental liver and kidney fibrosis.Involvement of B-cell CLL/lymphoma 2 promoter methylation in cigarette smoke extract-induced emphysema.Downregulation of IFNG in CD4(+) T cells in lung cancer through hypermethylation: a possible mechanism of tumor-induced immunosuppression.MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.Epigenetics in endometrial carcinogenesis - part 1: DNA methylation.The clinicopathological significance and potential drug target of E-cadherin in NSCLC.Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets.Recent findings on epigenetic gene abnormalities involved in uterine cancer.Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway.
P2860
Q26771827-C36DAC99-C71F-4A81-AB09-56DB2D17231BQ26865748-C740CA93-C0F6-4DC7-BB71-FFD939AC3CDFQ26865904-4ADDE598-287F-4F24-BDBA-F6B73ABE3F35Q28384159-CCCAC102-13D0-4A0D-A565-565A417DA657Q35311768-1554B488-07D6-4A4B-9321-0F73EE54D88EQ36588493-5C872C42-D017-4737-9B91-F0379E7AAF9CQ37107240-E8A8B220-7CC9-4B0B-9938-3385A96AE7F8Q37297734-974D55E1-6CF6-4780-A1C8-2B67C79814BBQ39210882-EC85D2DC-D7E8-479B-A28F-24CBDBA99E2AQ39282288-8DA2A467-DFA7-454D-9181-CEAF1F724E21Q41252193-BC15EFE0-6966-4A60-85E4-D38B92A87D3BQ42922825-9D72BE9D-EB62-468B-898F-3C5E8B06E6F4Q47153989-D2E80892-7B00-4262-B88B-A59063FAFFE0Q55492494-07F2B3A8-183D-4C35-8F54-A4CDBDE709DC
P2860
DNMT inhibitors and HDAC inhibitors regulate E-cadherin and Bcl-2 expression in endometrial carcinoma in vitro and in vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
DNMT inhibitors and HDAC inhib ...... arcinoma in vitro and in vivo.
@en
DNMT inhibitors and HDAC inhib ...... arcinoma in vitro and in vivo.
@nl
type
label
DNMT inhibitors and HDAC inhib ...... arcinoma in vitro and in vivo.
@en
DNMT inhibitors and HDAC inhib ...... arcinoma in vitro and in vivo.
@nl
prefLabel
DNMT inhibitors and HDAC inhib ...... arcinoma in vitro and in vivo.
@en
DNMT inhibitors and HDAC inhib ...... arcinoma in vitro and in vivo.
@nl
P2093
P2860
P356
P1433
P1476
DNMT inhibitors and HDAC inhib ...... arcinoma in vitro and in vivo.
@en
P2093
Hai-Di Sun
Quanxin Qu
Tie-Zhong Yi
Wen-Hua Tan
P2860
P356
10.1159/000333077
P577
2012-02-10T00:00:00Z